Omega-3 Fatty Acids in Treating Women With Newly Diagnosed Ductal Carcinoma In Situ and/or Atypical Ductal Hyperplasia

Completed · Not applicable · Has a placebo group

Conditions studied: Breast Cancer, Precancerous Condition

In brief

RATIONALE: Polyunsaturated fatty acids are important for normal growth and development. One type, called omega-3 fatty acids (found in fish, fish oil, and some other foods), may affect the growth of abnormal breast cells. PURPOSE: This randomized pilot trial is studying how well omega-3 fatty acids work in treating women with newly diagnosed ductal carcinoma in situ and/or atypical ductal hyperplasia.

Key facts

Study ID

NCT00627276

Run by

OHSU Knight Cancer Institute

People needed

16

Starts

2007-12-01

Expected to finish

2013-11-01

Last updated by the study team

2017-04-27

Who can join

Age: 21 and older, up to 120. Sex: female. Healthy volunteers: not accepted.

Where it is running

• Epic Imaging — Portland, Oregon, United States
• Knight Cancer Institute at Oregon Health and Science University — Portland, Oregon, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.